Beximco Sukuk Bond Granted Share Conversion Approval

Industry: Healthcare & Pharma, Pharma
Company: Beximco Pharmaceuticals Limited
Company Intelligence Tag: Business Insights

Beximco Limited, the first private sector company in Bangladesh, has been granted permission by the Bangladesh Securities and Exchange Commission (BSEC) to convert its Tk3,000 crore Sukuk bond into shares without needing prior approval. The Sukuk bond was issued in 2021 to finance the company’s solar power plants and textile division’s green expansion.

Investors, primarily banks and institutions, have the option to convert 20% of their Sukuk units into Beximco shares annually, enjoying a 25% discount from the 20-day average closing share price before the record date. The unexecuted conversion rights can also be exercised in later years.

Beximco has already seen around Tk170 crore worth of Beximco Green Sukuk converted into common shares in the first year. This amounted to over 1.96 crore new shares being credited to 325 Sukuk investors’ accounts. However, around 70% of Sukuk investors chose to retain their income investment, as they were receiving robust double-digit annual returns from the Sukuk. The conversion resulted in a 2.24% increase in Beximco’s total shares.

To streamline the process and eliminate complications, BSEC exempted Beximco from obtaining separate approval for increasing the paid-up capital through share issuance. This move aims to facilitate smoother and more efficient conversion of Sukuk units into shares.

The trustee of the Beximco Green Sukuk Al Istisna’a has also approved a 5.55% profit payment for the first half of the Sukuk’s second year. The Sukuk has been trading on the stock exchanges since January 2022, with the current trading value at Tk85 on the Dhaka Stock Exchange (DSE).

Source for more details:

Related News

Beximco to Manage Own Firms as HC Cancels Receiver Order

March 15, 2025

The High Court (HC) has canceled its previous order to appoint a receiver for managing Beximco Group companies, allowing them to operate under their own management while being supervised by Bangladesh Bank and other regulatory bodies.

Vice Chairman of Square Pharma to Acquire 15 Lakh Shares

March 13, 2025

Ratna Patra, vice chairman and sponsor of Square Pharmaceuticals, announced her plan to purchase 15 lakh shares worth approximately Tk 33 crore at the current market price. The purchase will take place within the next 30 working days through both public and block markets on the Dhaka Stock Exchange (DSE).

NBR Cuts Advance Tax on Cancer Drug Materials to 2%

March 12, 2025

The National Board of Revenue (NBR) has exempted the advance tax (AT) on the import of raw materials for cancer drug manufacturing, aiming to reduce production costs and drug prices. Previously, a 5% AT was imposed, but it has now been reduced to 2% or eliminated altogether.

Square Pharma Chairman to Buy 15 Lakh Shares for Tk 32 Crore

March 11, 2025

Samuel S Chowdhury, chairman of Square Pharmaceuticals, plans to buy 15 lakh shares worth over Tk 32 crore within 30 working days through the Dhaka Stock Exchange (DSE). As of November 30, 2023, he held a 9.32% stake, which will rise to 9.49% after the purchase.

Pharma Exports Grow 7.1% in Eight Months of FY24-25

March 10, 2025

Bangladesh's pharmaceutical exports saw steady growth in the first eight months of FY24-25, earning $145.46 million, a 7.1% increase from $135.81 million in the same period of the previous year. Growth was driven by rising demand in developed markets like the US, Australia, and Europe.

Govt Provides Tk 525.46 Crore to Beximco for Worker Dues

March 8, 2025

The government has provided Tk 525.46 crore to Beximco Group to settle dues for workers and officials of 14 closed textile and garment units. The funds, allocated by the finance division, will be disbursed as a loan, which Beximco must repay later.

Related News

Beximco to Manage Own Firms as HC Cancels Receiver Order

March 15, 2025

The High Court (HC) has canceled its previous order to appoint a receiver for managing Beximco Group companies, allowing them to operate under their own management while being supervised by Bangladesh Bank and other regulatory bodies.

Vice Chairman of Square Pharma to Acquire 15 Lakh Shares

March 13, 2025

Ratna Patra, vice chairman and sponsor of Square Pharmaceuticals, announced her plan to purchase 15 lakh shares worth approximately Tk 33 crore at the current market price. The purchase will take place within the next 30 working days through both public and block markets on the Dhaka Stock Exchange (DSE).

NBR Cuts Advance Tax on Cancer Drug Materials to 2%

March 12, 2025

The National Board of Revenue (NBR) has exempted the advance tax (AT) on the import of raw materials for cancer drug manufacturing, aiming to reduce production costs and drug prices. Previously, a 5% AT was imposed, but it has now been reduced to 2% or eliminated altogether.

Square Pharma Chairman to Buy 15 Lakh Shares for Tk 32 Crore

March 11, 2025

Samuel S Chowdhury, chairman of Square Pharmaceuticals, plans to buy 15 lakh shares worth over Tk 32 crore within 30 working days through the Dhaka Stock Exchange (DSE). As of November 30, 2023, he held a 9.32% stake, which will rise to 9.49% after the purchase.

Pharma Exports Grow 7.1% in Eight Months of FY24-25

March 10, 2025

Bangladesh's pharmaceutical exports saw steady growth in the first eight months of FY24-25, earning $145.46 million, a 7.1% increase from $135.81 million in the same period of the previous year. Growth was driven by rising demand in developed markets like the US, Australia, and Europe.

Govt Provides Tk 525.46 Crore to Beximco for Worker Dues

March 8, 2025

The government has provided Tk 525.46 crore to Beximco Group to settle dues for workers and officials of 14 closed textile and garment units. The funds, allocated by the finance division, will be disbursed as a loan, which Beximco must repay later.

BUSINESSMONITOR

Connect with


Dont Have Account? Please register Here